Department of Pharmacy, Emergency General Hospital, Beijing, China.
Eur Rev Med Pharmacol Sci. 2019 Apr;23(7):3096-3104. doi: 10.26355/eurrev_201904_17593.
The aim of this research was to explore the protective effect of lycopene (Lyc) on myocardial ischemia injury through anti-apoptosis and anti-oxidative stress.
75 rats were divided into 5 groups: sham operation group (control group), model group, low-dose group (Lyc+2 mg/kg), medium-dose group (Lyc+4 mg/kg) and high-dose group (Lyc+6 mg/kg). The rat model of myocardial ischemia was established by a subcutaneous injection of isoproterenol (85 mg/kg) for two consecutive days. Conventional HE staining and Masson staining were performed for pathological changes. Biochemical indicators were measured by the enzyme-linked immuno sorbent assay (ELISA). Western blotting was used to measure the levels of related proteins in JNK/STAT signaling pathway.
Compared to control group, the levels of CK-MB, TC, and TGs were significantly increased in model group. The levels of CK-MB, TC, and TGs in each Lyc-administered group were decreased. After Lyc was administered, the SOD, CAT, GSH-Px activities and MDA content were all restored. The serum levels of IL-1β, TNF-α and IL-6 in control group were significantly lower than in model group. When the Lyc was administered, the serum IL-1β, TNF-α and IL-6 levels in medium-dose group and high-dose group were significantly decreased. The levels of Bax/Bcl-2, Cyt-c, and Caspase-3 in model group were significantly higher than control group. Changes of Bax/Bcl-2, Cyt-c, and Caspase-3 in medium-dose and high-dose groups after the administration of Lyc were restored significantly. The levels of p-JNK/JNK, p-STAT1 (Tyr701)/STAT1, p-STAT1 (Ser727)/STAT1, p-STAT3 (Tyr705)/STAT3 were significantly increased, while p-STAT3 (Ser727)/STAT3 was significantly decreased. When Lyc was administered, the expression levels of p-JAK/JAK, p-STAT1 (Tyr701)/STAT1, p-STAT1 (Ser727)/STAT1, p-STAT3 (Tyr705)/STAT3 protein in medium-dose group and high-dose group were significantly decreased, and the expression level of p-STAT3 (Ser727)/STAT3 protein was significantly increased.
Lyc could show a protective effect on oxidative stress injury and anti-cardiomyocyte apoptosis of myocardial ischemia, and its possible mechanism was to attenuate the activation of JNK/ERK signaling pathway induced by myocardial injury.
本研究旨在探讨番茄红素(Lyc)通过抗细胞凋亡和抗氧化应激对心肌缺血损伤的保护作用。
75 只大鼠随机分为 5 组:假手术组(对照组)、模型组、低剂量组(Lyc+2 mg/kg)、中剂量组(Lyc+4 mg/kg)和高剂量组(Lyc+6 mg/kg)。通过连续两天皮下注射异丙肾上腺素(85 mg/kg)建立大鼠心肌缺血模型。采用常规 HE 染色和 Masson 染色观察病理变化。采用酶联免疫吸附试验(ELISA)法测定生化指标。采用 Western blot 法测定 JNK/STAT 信号通路相关蛋白水平。
与对照组相比,模型组 CK-MB、TC 和 TGs 水平显著升高。各 Lyc 给药组 CK-MB、TC 和 TGs 水平均降低。给予 Lyc 后,SOD、CAT、GSH-Px 活性和 MDA 含量均得到恢复。对照组血清中 IL-1β、TNF-α和 IL-6 水平明显低于模型组。给予 Lyc 后,中、高剂量组血清中 IL-1β、TNF-α和 IL-6 水平明显降低。模型组 Bax/Bcl-2、Cyt-c 和 Caspase-3 水平明显高于对照组。中、高剂量组给予 Lyc 后 Bax/Bcl-2、Cyt-c 和 Caspase-3 水平明显恢复。模型组 p-JNK/JNK、p-STAT1(Tyr701)/STAT1、p-STAT1(Ser727)/STAT1、p-STAT3(Tyr705)/STAT3 水平明显升高,而 p-STAT3(Ser727)/STAT3 水平明显降低。给予 Lyc 后,中、高剂量组 p-JAK/JAK、p-STAT1(Tyr701)/STAT1、p-STAT1(Ser727)/STAT1、p-STAT3(Tyr705)/STAT3 蛋白表达水平明显降低,p-STAT3(Ser727)/STAT3 蛋白表达水平明显升高。
Lyc 对心肌缺血氧化应激损伤和抗心肌细胞凋亡具有保护作用,其作用机制可能是减轻心肌损伤诱导的 JNK/ERK 信号通路的激活。